<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study

Loading...
Thumbnail Image

Departments

Item type:Organizational Unit,

School / College / Institute

Item type:Organizational Unit,
SCHOOL OF MEDICINE
Upper Org Unit

Program

Organization Authors

Co-Authors

Dumot, Chloe

Pikis, Stylianos

Mantziaris, Georgios

Xu, Zhiyuan

Anand, Rithika Kormath

Nabeel, Ahmed M.

Sheehan, Darrah

Sheehan, Kimball

Reda, Wael A.

Tawadros, Sameh R.

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Purpose: Surgery is the treatment of choice for large vestibular schwannomas (VS). Stereotactic radiosurgery (SRS) has been suggested as an alternative to resection in selected patients. However, the safety and efficacy of SRS in Koos grade IV patients <= 45 years old has not been evaluated. The aim of this study is to describe the clinical and radiological outcomes of Koos grade IV in young patient managed with a single-session SRS. Methods: This retrospective, multicenter analysis included SRS-treated patients, <= 45 years old presenting with non-life threatening or incapacitating symptoms due to a Koos Grade IV VS and with follow-up >= 12 months. Tumor control and neurological outcomes were evaluated. Results: 176 patients [median age of 36.0 (IQR 9) and median tumor volume of 9.3 cm(3) (IQR 4.7)] were included. The median prescription dose was 12 Gy (IQR 0.5). Median follow-up period was 37.5 (IQR 53.5) months. The 5- and 10-year progression-free survival was 90.9% and 86.7%. Early tumor enlargement occurred in 10.9% of cases and was associated with tumor progression at the last follow-up. The probability of serviceable hearing preservation at 5- and 10-years was 56.8% and 45.2%, respectively. The probability of improvement or preservation of facial nerve function was 95.7% at 5 and 10-years. Adverse radiation effects were noted in 19.9%. New-onset hydrocephalus occurred in 4.0%. Conclusion: Single-session SRS is a safe and effective alternative to surgical resection in selected patients <= 45 years old particularly those with medical co-morbidities and those who decline resection. Longer term follow up is warranted.

Source

Publisher

Springer

Subject

Citation

item.page.haspartof

Source

Journal of Neuro-Oncology

item.page.ispartofseries

item.page.edition

DOI

10.1007/s11060-022-04134-0

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Item type:Goal, Access status: Open Access ,
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.
Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators